These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 35345064)
1. Guillain-Barré Syndrome in Mexico: An Updated Review Amid the Coronavirus Disease 2019 ERA. Galnares-Olalde JA; López-Hernández JC; García-Grimshaw M; Valdés-Ferrer SI; Briseño-Godínez ME; de-Sarachaga AJ; Alegría-Loyola MA; Bazán-Rodriguez A; Martínez-Jiménez E; Vargas-Cañas ES Rev Invest Clin; 2022 May; 74(3):121-130. PubMed ID: 35345064 [TBL] [Abstract][Full Text] [Related]
2. Incidence of Guillain-Barré syndrome following SARS-CoV-2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines. García-Grimshaw M; Galnares-Olalde JA; Bello-Chavolla OY; Michel-Chávez A; Cadena-Fernández A; Briseño-Godínez ME; Antonio-Villa NE; Núñez I; Gutiérrez-Romero A; Hernández-Vanegas L; Del Mar Saniger-Alba M; Carrillo-Mezo R; Ceballos-Liceaga SE; Carbajal-Sandoval G; Flores-Silva FD; Díaz-Ortega JL; Cortes-Alcalá R; Pérez-Padilla JR; López-Gatell H; Chiquete E; Reyes-Terán G; Arauz A; Valdés-Ferrer SI Eur J Neurol; 2022 Nov; 29(11):3368-3379. PubMed ID: 35841212 [TBL] [Abstract][Full Text] [Related]
3. Guillain-Barre syndrome in Mexico: clinical features and validation of Brighton Collaboration Group criteria. López-Hernández JC; Galnares-Olalde JA; Gutiérrez A; Estrada SA; García-Grimshaw M; Vargas-Cañas ES Rev Neurol; 2022 Apr; 74(8):258-264. PubMed ID: 35383873 [TBL] [Abstract][Full Text] [Related]
4. Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barré syndrome? Zheng X; Fang Y; Song Y; Liu S; Liu K; Zhu J; Wu X Eur J Med Res; 2023 Feb; 28(1):98. PubMed ID: 36841799 [TBL] [Abstract][Full Text] [Related]
5. Current status of Guillain-Barré syndrome (GBS) in China: a 10-year comprehensive overview. Song Y; Zheng X; Fang Y; Liu S; Liu K; Zhu J; Wu X Rev Neurosci; 2023 Dec; 34(8):869-897. PubMed ID: 37145885 [TBL] [Abstract][Full Text] [Related]
7. Guillain-Barré syndrome in an era of global infections and 21st century vaccination. Lunn MP Curr Opin Neurol; 2022 Oct; 35(5):571-578. PubMed ID: 36069416 [TBL] [Abstract][Full Text] [Related]
8. Guillain-Barre syndrome should be monitored upon mass vaccination against SARS-CoV-2. Leung C Hum Vaccin Immunother; 2021 Sep; 17(9):2957-2958. PubMed ID: 34032555 [TBL] [Abstract][Full Text] [Related]
9. A Case Report of Guillain-Barré Syndrome In Association with SARS-CoV-2 Vaccination in Malaysia. Sii HL; Ng SH; Wong VF; Law WC Acta Neurol Taiwan; 2023 Dec; 32(4)():207-211. PubMed ID: 37723913 [TBL] [Abstract][Full Text] [Related]
10. Guillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports. Abuawwad MT; Taha MJJ; Taha AJ; Kozaa YA; Falah O; Abuawwad IT; Hammad EM; Mahmoud AA; Aladawi M; Serhan HA Clin Neurol Neurosurg; 2024 Mar; 238():108183. PubMed ID: 38401232 [TBL] [Abstract][Full Text] [Related]
12. Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child. Akçay N; Menentoğlu ME; Bektaş G; Şevketoğlu E J Med Virol; 2021 Sep; 93(9):5599-5602. PubMed ID: 33851741 [TBL] [Abstract][Full Text] [Related]
13. Guillain-Barré syndrome in patients with SARS-CoV-2 infection. Report of three cases. Cea G; Romero C; Aguilar S; Salinas R Rev Med Chil; 2021 Dec; 149(12):1812-1816. PubMed ID: 35735350 [TBL] [Abstract][Full Text] [Related]
14. A Case of Guillain-Barré Syndrome Associated With COVID-19. Rajdev K; Victor N; Buckholtz ES; Hariharan P; Saeed MA; Hershberger DM; Bista S J Investig Med High Impact Case Rep; 2020; 8():2324709620961198. PubMed ID: 32981333 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 and Guillain-Barré Syndrome: Lessons from Viral Infections. Meidaninikjeh S; Sabouni N; Taheri M; Borjkhani M; Bengar S; Majidi Zolbanin N; Khalili A; Jafari R Viral Immunol; 2022 Jul; 35(6):404-417. PubMed ID: 35766944 [TBL] [Abstract][Full Text] [Related]
16. Real-world data on the incidence and risk of Guillain-Barré syndrome following SARS-CoV-2 vaccination: a prospective surveillance study. Ha J; Park S; Kang H; Kyung T; Kim N; Kim DK; Kim H; Bae K; Song MC; Lee KJ; Lee E; Hwang BS; Youn J; Seok JM; Park K Sci Rep; 2023 Mar; 13(1):3773. PubMed ID: 36882454 [TBL] [Abstract][Full Text] [Related]
17. Association Between Guillain-Barré Syndrome and COVID-19 Infection and Vaccination: A Population-Based Nested Case-Control Study. Bishara H; Arbel A; Barnett-Griness O; Bloch S; Cohen S; Najjar-Debbiny R; Gronich N; Auriel E; Saliba W Neurology; 2023 Nov; 101(20):e2035-e2042. PubMed ID: 37852786 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2-associated Guillain-Barré syndrome in four patients: what do we know about pathophysiology? Guilmot A; Maldonado Slootjes S; Bissay V; Dubuisson N; de Broglie C; Gille M Acta Neurol Belg; 2022 Jun; 122(3):703-707. PubMed ID: 34476752 [TBL] [Abstract][Full Text] [Related]
19. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome. Keddie S; Pakpoor J; Mousele C; Pipis M; Machado PM; Foster M; Record CJ; Keh RYS; Fehmi J; Paterson RW; Bharambe V; Clayton LM; Allen C; Price O; Wall J; Kiss-Csenki A; Rathnasabapathi DP; Geraldes R; Yermakova T; King-Robson J; Zosmer M; Rajakulendran S; Sumaria S; Farmer SF; Nortley R; Marshall CR; Newman EJ; Nirmalananthan N; Kumar G; Pinto AA; Holt J; Lavin TM; Brennan KM; Zandi MS; Jayaseelan DL; Pritchard J; Hadden RDM; Manji H; Willison HJ; Rinaldi S; Carr AS; Lunn MP Brain; 2021 Mar; 144(2):682-693. PubMed ID: 33313649 [TBL] [Abstract][Full Text] [Related]
20. COVID-19 as a trigger of Guillain-Barré syndrome: A review of the molecular mechanism. Malekpour M; Khanmohammadi S; Meybodi MJE; Shekouh D; Rahmanian MR; Kardeh S; Azarpira N Immun Inflamm Dis; 2023 May; 11(5):e875. PubMed ID: 37249286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]